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Breast massesAbstract Purpose: This study aimed to emphasize the value of DW-MRI, ADC values in
differentiation of various breast masses.
Patients and methods: Between ‘‘June 2013 to January 2015’’, 50 consecutive patients with suspi-
cious breast lesions underwent DW-MRI and ADC with the measurement of ADC values. All
patients were examined with 1.5 Tesla MRI machine using breast coil. The images were obtained
with b-values 0 and 750 s/mm2. The ADC values were calculated for breast lesions and axillary
LNs. The results were correlated with the histopathology results which were taken as gold standard.
Results: In the studied 50 lesions, 20 were benign and 30 were malignant. The most frequent benign
lesion was ﬁbroadenoma (16%) and the most frequent malignant lesion was invasive duct carci-
noma (36%). The mean ADC value for benign lesions was 1.6 ± 0.33 · 103 mm2/s while the mean
ADC value for malignant lesions was 0.84 ± 0.25 · 103 mm2/s. The ROC curve showed that the
best ADC cut-off value between benign and malignant lesions was 1.02 · 103 mm2/s with sensitiv-
ity, speciﬁcity, PPV, NPV and accuracy of 90%, 95%, 100%, 90.4% and 92% respectively.
Conclusion: DW-MRI with ADC values measurement was considered a useful tool for accurate
differentiation of various breast masses.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Breast cancer is one of the leading causes of death from cancer
in women (1). Methods such as X-ray mammography, ultra-
sound and physical examination are often limited in sensitivity
and speciﬁcity, especially in young women. MRI is being
increasingly used for preoperative local staging, localization
of multiple lesions and screening of high-risk patients (2).
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phy and ultrasonography (US), can show tissue perfusion
characteristics of the masses on breast parenchyma, as well
as morphologic features, such as the contour, size, and shape
of the breast lesions. Although conventional MRI sequences
have an important role in the differential diagnosis of breast
masses, this technology has a low speciﬁcity, and thus requires
the support of additional imaging techniques (3–5). Diffusion-
Weighted MRI (DW-MRI) is an active ﬁeld of research in
MRI. In addition to diffusion-weighted imaging (DWI),
apparent diffusion coefﬁcient (ADC) maps can be created
and quantitative measurements can be performed. DW-MRI
provides physiologic information about the movement of
water in normal versus pathological tissue. The quantitative
measure of DWI (ADC value) has been reported to be inver-
sely correlated with tissue cellular density (6–9).
The aim of this study was to evaluate the role of DW-MRI
and ADC values in the differentiation of various breast
lesions.
2. Patients and methods
2.1. Patients
This study was approved by the ethics committee of our
institutions during the period between ‘‘June 2013 to January
2015’’. It included 50 consecutive female patients with a suspi-
cious breast mass diagnosed with mammography or US and
considered for a biopsy procedure. The ages of the patients
ranged from 28 to 71 years (median ± 49 years). Written
informed consent was obtained from each patient.
2.2. Inclusion criteria
Any suspicious lesion on mammography or US according to
Breast Imaging-Reporting and Data System (BI-RADS) crite-
ria and who were recommended for biopsy procedure were
included in the study.
2.3. Exclusion criteria
The patients who had general contraindications for MRI
examination and contrast-medium injections, patients who
rejected MR examination, patients who had noisy or non-
diagnostic DWI examinations due to motion artifacts and
patients who refused to undergo a biopsy were excluded from
the study.
2.4. The gold standard
All patients had MRI prior to the biopsy procedure. DWI and
ADC values were compared with the histopathology results,
which were taken as gold standard.
2.5. MRI protocol and technique
All MRIs were obtained using 1.5 Tesla superconducting unit
(Toshiba Medical systems corporation, 1385, Shimoishi Gami,
Otawara-Shi, Tochigi-Ken, Japan) with eight-channel CP
breast Array coil. Conventional sequences of routine breastMRI were performed for all patients, including axial fat-
suppressed T2-weighted (TR/TE, 2500/60 ms; slice thickness
3 mm and matrix 340 · 512), axial T1-weighted (TR/TE,
500/15 ms), axial STIR (TR/TE, 6500/84), fat saturation
sequence (TR/TE, 4300/80) and contrast-enhanced three-
dimensional dynamic fat-suppressed axial T1-weighted
(TR/TE 4.4/1.6 ms and slice thickness 1 mm). One pre-
contrast sequence was followed by six post-contrast sequences
for the dynamic contrast-enhanced images. Gad-DETPA
(gadolinium-Diethylene triamine penta-acetic acid) was used
as contrast media. The contrast media were given intra-
venously over 20 s by an automatic MR-compatible injector.
The doses were 0.2 mmol/kg (maximum dose 15 mmol).
The DWIs that formed the basis of our study were
performed prior to contrast-enhanced examination. The
DW-MRI sequences were performed with a two-dimensional
echo-planar imaging (EPI) sequence (TR/TE, 8200/95 ms
and slice thickness 3.5 mm) in the axial plane. The ADC
map images were created automatically by the system at two
different b values (b= 0 and 750 s/mm2).
2.6. Lesion assessment
All the lesions were evaluated by one radiologist according to
size, location, shape, signal intensity and contrast enhance-
ment patterns. The DW-MRIs were analyzed to observe any
restriction of diffusion in the lesions, and the ADC maps were
used for ADC value measurements. Each lesion was evaluated
on T1, T2-weighted, STIR, fat saturation and contrast-
enhanced images; the enhanced part of the lesion was preferred
for evaluation on the corresponding DW-MRI; the region of
interest (ROI) was placed manually on the corresponding area
of the ADC map. The ROI was placed in the solid portion of
the tumors and necrotic or cystic components were excluded
from the measurement area.
2.7. Post-imaging processing
All image analysis were performed by one experienced
Radiologist. ADC maps were constructed on a pixel by pixel
basis. Multiple ROIs were placed on either the breast lesions
or LNs on the ADC map and the average value was recorded.
All detected lesions were reviewed for enhancement pattern
and type of the time-intensity curve.
2.8. Surgical interference and pathological examination
Radical and modiﬁed radical mastectomy with LN excision
was done for 30 patients that proved pathologically to be
malignant while lumpectomy was done for the benign proved
lesions. Also radiotherapy and chemotherapy were additional
treatment measures for the malignant lesions according to
the pathology done after the excision.
2.9. Statistical analysis
Data entry and analysis were done with using the program
Statistical Package for the Social Sciences (SPSS).
Quantitative data were presented by mean and standard
deviation, while qualitative data were presented by frequency
Table 2 Correlation of conventional MRI ﬁndings to the
histopathology in studied patients (n= 50).
Conventional MRI Pathology P
Benign Malignant
N= 20 N= 30
Benign (n= 25) 19(76%) 6(24%) 0.001*
Malignant (n= 23) 1(4.3%) 22(95.7%)
Indeterminate (n= 2) 0 2(100%)
* Statistically signiﬁcant P value 0.001.
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groups were compared using Student’s t test. The sensitivity,
speciﬁcity, negative and positive predictive values (PPV) were
assessed. Also, the ROC analysis was performed to distinguish
between the thresholds ADC values of the benign and malig-
nant lesions. P< 0.05 was considered statistically signiﬁcant.
3. Results
This study included 50 consecutive female patients with 50
breast lumps, the clinical, radiological as well as pathological
ﬁndings, all were represented in tables and statistical forms.
3.1. Histopathological diagnosis
Of the 50 lesions, 20 were benign; the most frequent of them
was ﬁbroadenoma (8/20), followed by intra-ductal papilloma
(5/20), fat necrosis, ﬁbrocystic changes and atypical ductal
hyperplasia (2/20 for each) and the least frequent was granulo-
matous mastitis (1/20). Thirty lesions were malignant; invasive
duct carcinoma was the most frequent (18/30), followed by
ductal carcinoma in-situ (5/30) and the least frequent was
medullary carcinoma (3/30) (Table 1).
When using the conventional MRI sequences that were
routinely done (T1WI, T2WI, STIR and fat saturation
sequences), we found that (25/50) patients were diagnosed
benign, (23/50) patients were diagnosed malignant and (2/50)
were indeterminate. When correlated with the pathological
diagnosis of these patients we found that among the 25
patients that were diagnosed benign by conventional MRI, 6
patients were diagnosed malignant by histopathology. One
patient diagnosed malignant by conventional MRI and diag-
nosed benign by pathological study. Also, the 2 patients that
were indeterminate by MRI proved pathologically to be
malignant (p-value was statistically signiﬁcant 0.001) (Table 2).
We measure the ADC values for all lesions and correlated
with the pathology of these lesions. We found that the benign
lesions had a mean ADC value of 1.6 · 103 mm2/s and stan-
dard of deviation 0.33 mm2/s; while the malignant lesions had
a mean ADC value of 0.84 · 103 mm2/s and standard of devi-
ation 0.25 mm2/s (Table 3).
When we used the DW MRI and ADC values for the
evaluation of our patients we found that 21 patients were diag-
nosed benign (one of them was diagnosed pathologically asTable 1 Histopathological types of breast lesions (n= 50).
Diagnosis Pathological type No %
Benign (n= 20) Fibroadenoma 8 16
Intra-ductal papilloma 5 10
Fat necrosis 2 4
Fibrocystic changes 2 4
Atypical ductal hyperplasia 2 4
Granulomatous mastitis 1 2
Malignant (n= 30) Invasive duct carcinoma 18 36
Ductal carcinoma in-situ 5 10
Invasive tubular carcinoma 4 8
Medullary carcinoma 3 6
Total 50 100malignant). Twenty-seven patients were diagnosed malignant
and all were proved pathologically to be malignant. Two
patients were indeterminate by DW-MRI and proved patho-
logically as one benign and one malignant with evident statis-
tically signiﬁcant P value 0.001 (Table 4).
Considering the ADC receiver operating characteristics
curve (ROC curve), we found that the ADC value was diag-
nostic for differentiation of breast masses as the area under
the curve measured 0.87 ± 0.05 and conﬁdence interval was
from 0.77 to 0.96. The cut off value between benign and malig-
nant lesions was found to be 1.02 mm2/s with signiﬁcant P
value < 0.001 (Table 5).
As regarding the differentiation of breast lesions, conven-
tional MRI had a sensitivity of 73.3%, speciﬁcity of 90% with
positive predictive value of 95.6%, negative predictive value of
76% and accuracy of 82%. While using the DW-MRI and
ADC value had sensitivity of 90%, speciﬁcity of 95% with pos-
itive predictive value of 100%, negative predictive value of
90.4% and higher accuracy for breast lesion differentiation
that reached 92% (Table 6).4. Discussion
DWI reﬂects changes in water molecule mobility caused by
alterations of the tissue environment due to a pathological pro-
cess. Therefore, measurement of the motion of water molecules
can provide an additional feature that may further increase the
speciﬁcity of the MRI classiﬁcation of breast masses. Also, the
measurement of the apparent diffusion coefﬁcient plays a sig-
niﬁcant adjuvant role with DW-MRI in the differentiation of
breast lesions as there is a direct relationship between ADC
values and tumor cellular structure (10–13).
In this study we found that the invasive duct carcinoma was
the most frequent malignant breast lesion and the ﬁbroade-
noma was the most frequent benign breast lesion. This was
also stated on recent study by Sahin and Aribal (14). Also, this
was proved by Blackledge et al., (3) (Table 1) (Figs. 1–4).
Considering the ADC values we found that the high values
were more toward benign lesions while the lower values were
toward the malignant nature of the lesions. The mean ADC
value for benign lesions was 1.60 · 103 mm2/s with the stan-
dard of deviation 0.33 · 103 mm2/s. While the mean ADC
value for malignant lesions was 0.84 · 103 mm2/s with the
standard of deviation 0.25 · 103 mm2/s with statistically
signiﬁcant P value 0.001 (Table 3). The ROC curve showed
that, the cut off value for differentiation between benign and
malignant lesions was 1.02 · 103 mm2/s and so that any
breast lesion with ADC value equal to or less than
Table 3 The average apparent diffusion coefﬁcient values of the malignant and benign lesions.
B value combination (s/mm2) ADC values (·103 mm2/s) P
Benign Malignant
Mean SD Median Mean SD Median
0 and 750 1.60 0.33 1.55 0.84 0.25 0.81 0.001*
* Statistically signiﬁcant P value 0.001.
Table 4 Correlation of DW MRI and ADC values to the
histopathology of our patients (n= 50).
DW MRI with ADC value
measurement
Pathology P
Benign
N= 20
Malignant
N= 30
Benign (n= 21) 19(90.5%) 2(9.5%) 0.001*
Malignant (n= 27) 0 27(100%)
Indeterminate (n= 2) 1(50%) 1(50%)
* Statistically signiﬁcant P value 0.001.
Table 5 Analysis of the ADC values of the breast lesions.
Item ADC
Classiﬁcation variable Diagnose
Sample size 50
Positive group (malignant) 27
Negative group (benign and indeterminate) 23
Area under the ROC curve 0.87 ± 0.05
Conﬁdence interval 0.77–0.96
P (area) <0.001
ROC: Receiver Operating Characteristics.
Fig. 1 A receiver operating characteristic (ROC curve) analysis
for the ADC values to differentiate various breast lesions.
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any breast lesion with ADC value more than
1.02 · 103 mm2/s, should be considered benign. Fernanda
et al. (9) stated that the mean ADC values obtained from
malignant lesions were 0.68–1.25 ± 0.25 with standard devia-
tion 0.25–0.28 · 103 mm2/s while that observed from benign
lesions 1.44–1.77 ± 0.31 with standard deviation
0.44 · 103 mm2/s. Also, Imamura et al. (15), reported that
the most feasible ADC value to depict malignant lesions was
found to be less than 1.10 · 103 mm2/s (see Fig. 5).
Yoshikawa et al. (16) reported that the use of small b values
increased the accuracy of differentiation between benign and
malignant lesions. This was in contrast to Sinha and Sinha
(17) that postulated, the use of high b-values decreased the
SNR. Fernanda et al. (9) found that the use of 0 and 750
b-values combination was the most appropriate and we
followed this protocol on this study. It was reported that theTable 6 Comparison between conventional MRI and DW-MRI w
MRI Sensitivity (%) S
Conventional 73.3 9
DW MRI with ADC value measurement. 90 9
Note: PPV = positive predictive value, NPV= negative predictive valueDW-MRI with high b-values was more reliable in differentiat-
ing between breast lesions, though signal loss more severe (3, 5
and 7). Bogner et al., (18) reported that using variable b-values
did not provide an advantage and reported ideal b-value as
850 s/mm2.
Correlating the results of conventional MRI with the
pathological results, 25 lesions were diagnosed benign by
MRI, 6 of them diagnosed pathologically malignant. On the
other hand, 23 patients were diagnosed by MRI malignant,
one of them was proved pathologically as benign. The other
2 lesions were in-determinate by conventional MRI and
proved pathologically as malignant. The indeterminate lesions
were the lesions that did not fulﬁl the criteria of either malig-
nant or benign lesion, regarding the lesion shape, signal inten-
sity, contrast enhancement, diffusion restriction or its ADC
value. These results were statistically signiﬁcant with P value
0.001 (Table 2). Nunes et al., (19) and Houssami (20) stated
that, despite of the high sensitivity of MRI, it showed low
speciﬁcity ranging from 40% to 80% and there were many
overlaps in the imaging ﬁndings for benign and malignant
lesions. In this research, the sensitivity of conventional MRIith ADC value measurements in diagnosis of breast lesions.
peciﬁcity (%) PPV (%) NPV (%) Accuracy (%)
0 95.6 76 82
5 100 90.4 92
.
Fig. 2 Female patient 58-year old complaining of Lt. breast swelling: Axial T1WI (A) revealed that a well-deﬁned 37 · 20 mm sized
retro-areolar hypointense signal lesion. Fat saturation post Gad (B), the lesion appeared more deﬁned with moderate heterogeneous
enhancement and a Lt. axillary similar lesion is seen 32 · 20 mm in size (C). On drawing the time intensity curve for the breast lesion, type
I curve was resulted showing rapid enhancement and rapid wash out (D and D1). DWI at 0 and 750 b-values showed non-homogenous
restriction of the lesion (E&E1) as well as the Lt. axillary lesion (F&F1) both lesions showed hyposignals on ADC map (E2 & F2). On
measuring the mean ADC value for the breast lesion was found to be 0.854 · 103 mm2/s and that for the axillary lesion was found to be
0.781 · 103 mm2/s. Pathological diagnosis was medullary carcinoma.
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Fig. 3 Female patient 35-year old complaining of Rt. breast mass: Axial T1 fat saturation (A) revealed 70 · 34.5 mm sized mid-portion
Rt. breast lesion that take heterogeneous enhancement after Gad injection (B). On drawing time intensity curve for this breast lesion, type
II plateau curve was noted (C). DWI (D) revealed heterogeneous restriction on the Rt. breast lesion and appearance of Rt. axillary
restricted lesion. On (D1) measuring the mean ADC value for the breast lesion 0.868 · 103 mm2/s and for the axillary lesion was found to
be 1.104 · 103 mm2/s. On (E & E1) DWI on 0 and 750 b-values revealed a restricted lesion on Rt. breast with mean ADC value
0.865 · 103 mm2/s. Pathological diagnosis was invasive duct carcinoma.
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Fig. 4 Female patient 55-year old presented by Rt. breast mass: Non-contrast axial T1 (A), revealed a 30 · 25 mm sized lesion on Rt.
breast at 10 & 11 O’clock displaying hypo signals and on T2WI (B), the lesion was seen heterogeneous hyper-intense. On post contrast
axial T1WI (C), the lesion takes moderate heterogeneous enhancement. On plotting the time intensity curve, type III benign curve was
seen. DWI at 0 and 750 b-values (E & E1), revealed hyper-intense lesion on Rt. breast that also noted hyper-intense on ADC map (G)
denoting false restriction (T2 shinne through) and its ADC value was 1.851 · 103 mm2/s. Pathological diagnosis was granulomatous
mastitis.
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Fig. 5 Female patient 20-year old presented by Rt. breast palpable mass: Axial T1W fat saturation (A) revealed 6.93 · 5.86 cm sized
lesion involving most of the Rt. breast parenchyma displaying hypointense signals. After Gad injection, the lesion takes patchy
enhancement on (A1) and the enhancement increased gradually as in (A2). When plotting the time intensity curve and put the cursor on
the region of interest (ROI) as in (B), type III pattern is identiﬁed as in (B1). DWI on 0 (c) and 750 b-value (C1), the lesion showed slight
restriction on (C) and no signiﬁcant restriction identiﬁed on (C1). ADC map (D) revealed non-homogenous hypersignals and
measurement of the mean ADC value was 2.064 · 103 mm2/s on (D1) and 1.812 · 103 mm2/s (D2). Pathological diagnosis was intra-
ductal papilloma.
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speciﬁcity 90%, PPV 95.6%, NPV 76% with accuracy of 82%
(Table 6). This was stated by Kim. et al., (21).
Correlating the results of DW-MRI and ADC values with
the pathological results, we found that 21 lesions diagnosedbenign by DW-MRI, 2 of them proved pathologically as
malignant. On the other hand 27 lesions diagnosed as malig-
nant by DW-MRI and all proved to be malignant by
histopathology. The remaining 2 lesions that were in-
determinate by DW-MRI proved pathologically as one benign
The utility of diffusion weighted MRI and apparent diffusion coefﬁcient 1265and one malignant lesion. Marini et al., (10) reported that the
use of DW-MRI in differentiating between malignant and
benign breast lesions had a sensitivity ranged from 81% to
93% and speciﬁcity from 80% to 88.5%; this was nearly stated
by Yabouuchi et al., (22) and Park et al. (23). In this study sen-
sitivity of DW-MRI with ADC values in the differential diag-
nosis of breast lesions reached 90% with speciﬁcity of 95%,
PPV of 100%, NPV of 90.4 and accuracy of 92%.
Liu et al., (24) postulated that the addition of DWI with
measurements of ADC values to the conventional MRI,
improved the detection and differentiation of various breast
lesions. Hetta (25) stated that the use of DWI combined with
breast MRI improved the detection and differentiation of
breast lesions with sensitivity, speciﬁcity, PPV, NPV and accu-
racy of 85%, 93.33%, 94.4%, 82.4% and 90.3% respectively.
5. Conclusion
According to the results of this study we concluded that the
addition of DW-MRI and ADC value measurements to the
conventional MRI of the breast increased the accuracy of diag-
nosis and characterization of different breast masses. Also, the
use of DW-MRI with ADC value measurements was found to
be a valuable quantitative analysis.
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